Advertisement.

MREO Projected Dividend Yield

ADR/Mereo BioPharma Group PLC ( NASDAQ : MREO )

Mereo Biopharma Group is a biopharmaceutical company focused on the development of therapeutics for rare diseases. Co.'s oncology and rare disease product candidates include: Setrusumab (BPS-804), which is an antibody designed to inhibit sclerostin, a protein that inhibits the activity of bone-forming cells; Alvelestat (MPH-966), which is an oral small molecule Co. is developing for the treatment of severe alpha-1 antitrypsin deficiency lung disease and bronchiolitis obliterans syndrome; and Etigilimab (MPH-313), which is an antibody against T-cell immunoreceptor with Ig and ITIM domains.

20 YEAR PERFORMANCE RESULTS

MREO Dividend History Detail
MREO Dividend News
MREO Competitors News

# of Shares: 0

Closing Price: 3.74

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000